Arix Bioscience PLC (LON:ARIX) Investment Associate Tim Xu tells Proactive what he believes are promising therapeutics currently being innovated by a variety of biotechs around the word.
Xu, who recently published a blog post entitled "How close are we to a COVID-19 cure? A biotech VC perspective" says he anticipates a potential vaccine to be developed by winter, early spring of 2021, while a treatment, he says, will take a considerably longer time frame.